Bollati-Fogolín Mariela, Forno Guillermina, Nimtz Manfred, Conradt Harald S, Etcheverrigaray Marina, Kratje Ricardo
Laboratorio de Cultivos Celulares, Facultad de Bioquímica y Ciencias Biológicas, Universidad Nacional del Litoral, Ciudad Universitaria--C.C. 242, S3000ZAA Santa Fe, Argentina.
Biotechnol Prog. 2005 Jan-Feb;21(1):17-21. doi: 10.1021/bp049825t.
We have demonstrated that temperature reduction from 37 to 33 degrees C in the culture of a CHO cell line producing recombinant human granulocyte macrophage colony stimulating factor (CHO-K1-hGM-CSF) leads to a reduced growth rate, increased cell viability, improved cellular productivity, and decreased cell metabolism. In the present study, CHO-K1-hGM-CSF cells were cultured in a biphasic mode: first, a 37 degrees C growth phase for achieving a high cell number, followed by a production phase where the culture temperature was shifted to 33 degrees C. The maximum cell density was not affected after temperature reduction while cell viability remained above 80% for a further 3.7 days in the culture kept at the lower temperature, when compared to the control culture maintained at 37 degrees C. Furthermore, the total rhGM-CSF production increased 6 times in the culture shifted to 33 degrees C. Because the quality and hence the in vivo efficacy of a recombinant protein might be affected by numerous factors, we have analyzed the N- and O-glycosylation of the protein produced under both cell culture conditions using high-pH anion-exchange chromatography and complementary mass spectrometry techniques. The product quality data obtained from the purified protein preparations indicated that decreasing temperature had no significant effect on the rhGM-CSF glycosylation profiles, including the degree of terminal sialylation. Moreover, both preparations exhibited the same specific in vitro biological activity. These results revealed that the employed strategy had a positive effect on the cell specific productivity of CHO-K1-hGM-CSF cells without affecting product quality, representing a novel procedure for the rhGM-CSF production process.
我们已经证明,在生产重组人粒细胞巨噬细胞集落刺激因子的CHO细胞系(CHO-K1-hGM-CSF)培养过程中,将温度从37℃降至33℃会导致生长速率降低、细胞活力增加、细胞生产力提高以及细胞代谢减少。在本研究中,CHO-K1-hGM-CSF细胞以双相模式培养:首先,在37℃的生长阶段以获得高细胞数量,随后是生产阶段,此时培养温度转变为33℃。与维持在37℃的对照培养相比,降温后最大细胞密度未受影响,而在较低温度下培养的细胞在另外3.7天内细胞活力仍保持在80%以上。此外,转移至33℃培养的rhGM-CSF总产量增加了6倍。由于重组蛋白的质量及其体内功效可能受到多种因素影响,我们使用高pH阴离子交换色谱和互补质谱技术分析了在两种细胞培养条件下产生的蛋白的N-糖基化和O-糖基化。从纯化的蛋白制剂获得的产品质量数据表明,降低温度对rhGM-CSF糖基化谱,包括末端唾液酸化程度没有显著影响。此外,两种制剂均表现出相同的体外比生物学活性。这些结果表明,所采用的策略对CHO-K1-hGM-CSF细胞的细胞比生产力有积极影响,且不影响产品质量。这代表了rhGM-CSF生产过程中的一种新方法。